pelargonium sidoides callus

callus of pelargonium sidoides grown in culture

CAS: 1175005-95-4

Identification

Namepelargonium sidoides callus
CAS Number1175005-95-4
FDA UNIISearch

Regulatory

Physical Properties

Food Chemicals Codex Listed No

Cosmetic Information

CosIngcosmetic data
Cosmetic Usesantioxidants

No sensory data available

Safety Information

Oral/Parenteral ToxicityNot determined
Dermal ToxicityNot determined
Inhalation ToxicityNot determined

GHS Classification

['GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)', 'GHS Label elements, including precautionary statements']

Safety in Use

Categoryantioxidants, hair conditioning, humectants
Recommendation for pelargonium sidoides callus usage levels up tonot for fragrance use.
Recommendation for pelargonium sidoides callus flavor usage levels up tonot for flavor use.

No supplier data available

Potential Uses

None Found

Natural Occurrence

pelargonium sidoides

Synonyms

callus of pelargonium sidoides grown in culture south african geranium callus umckaloabo callus PubMed: Herbal Medicine for Cough: a Systematic Review and Meta-Analysis. PubMed: Anti-proliferative properties of commercial Pelargonium sidoides tincture, with cell-cycle G0/G1 arrest and apoptosis in Jurkat leukaemia cells. PubMed: Herb-Induced Liver Injury in the Berlin Case-Control Surveillance Study. PubMed: A review of commercially important African medicinal plants. PubMed: The Pelargonium sidoides Extract EPs 7630 Drives the Innate Immune Defense by Activating Selected MAP Kinase Pathways in Human Monocytes. PubMed: Reproduction of the Medicinal Plant Pelargonium sidoides via Somatic Embryogenesis. PubMed: Evaluation of pharmacodynamic activities of EPs® 7630, a special extract from roots of Pelargonium sidoides, in animals models of cough, secretolytic activity and acute bronchitis. PubMed: [Herbal medicines against respiratory diseases--traditional empiricism or pharmacological evidence?]. PubMed: The root extract of the medicinal plant Pelargonium sidoides is a potent HIV-1 attachment inhibitor. PubMed: Medicinal properties and conservation of Pelargonium sidoides DC. PubMed: EPs7630(®) from Pelargonium sidoides increases stress resistance in Caenorhabditis elegans probably via the DAF-16/FOXO pathway. PubMed: Pelargonium sidoides extract for treating acute respiratory tract infections. PubMed: Positioning of the Bronchitis Severity Score (BSS) for standardised use in clinical studies. PubMed: Evaluation of molecular chaperons Hsp72 and neuropeptide Y as characteristic markers of adaptogenic activity of plant extracts. PubMed: Conservation strategy for Pelargonium sidoides DC: phenolic profile and pharmacological activity of acclimatized plants derived from tissue culture. PubMed: Herbal hepatotoxicity: suspected cases assessed for alternative causes. PubMed: Herbal medicine, randomised controlled trials and global core competencies. PubMed: Randomised, double-blind, placebo-controlled trial of EPs 7630 in adults with COPD. PubMed: Adverse effects of herbal medicines: an overview of systematic reviews. PubMed: Can the Pelargonium sidoides root extract EPs® 7630 prevent asthma attacks during viral infections of the upper respiratory tract in children? PubMed: Treatment of the common cold in children and adults. PubMed: African Geranium (EPs 7630), part 2: the efficacy of Pelargonium sidoides (EPs 7630) in the treatment of acute bronchitis in adults and children. PubMed: Adverse drug reactions for CAM and conventional drugs detected in a network of physicians certified to prescribe CAM drugs. PubMed: The efficacy of Pelargonium sidoides in the treatment of upper respiratory tract infections in children with transient hypogammaglobulinemia of infancy. PubMed: Spontaneous reports of primarily suspected herbal hepatotoxicity by Pelargonium sidoides: Was causality adequately ascertained? PubMed:  Initially purported hepatotoxicity by Pelargonium sidoides: the dilemma of pharmacovigilance and proposals for improvement. PubMed: Synergistic Antimycobacterial Actions of Knowltonia vesicatoria (L.f) Sims. PubMed: EPs® 7630 (Umckaloabo®), an extract from Pelargonium sidoides roots, exerts anti-influenza virus activity in vitro and in vivo. PubMed: Spontaneous reports of primarily suspected herbal hepatotoxicity by Pelargonium sidoides: was causality adequately ascertained? PubMed: Treatment of acute bronchitis with EPs 7630: randomized, controlled trial in children and adolescents. PubMed: African geranium (EPs 7630), part I: a proprietary root extract of Pelargonium sidoides (EPs 7630) is found to be effective in resolving symptoms associated with the common cold in adults. PubMed: [Pelargonium sidoides - oral (Kaloban).]. PubMed: [Pelargonium sidoides in acute bronchitis - Health-related quality of life and patient-reported outcome in adults receiving EPs 7630 treatment]. PubMed: Anti-infective activities of Pelargonium sidoides (EPS® 7630): effects of induced NO production on Leishmania major in infected macrophages and antiviral effects as assessed in a fibroblast-virus protection assay. PubMed: Investigation of the influence of EPs® 7630, a herbal drug preparation from Pelargonium sidoides, on replication of a broad panel of respiratory viruses. PubMed: Anti-adhesive activities of flavan-3-ols and proanthocyanidins in the interaction of group A-streptococci and human epithelial cells. PubMed: Evaluation of an aqueous-ethanolic extract from Pelargonium sidoides (EPs® 7630) for its activity against group A-streptococci adhesion to human HEp-2 epithelial cells. PubMed: Immune responses induced by Pelargonium sidoides extract in serum and nasal mucosa of athletes after exhaustive exercise: modulation of secretory IgA, IL-6 and IL-15. PubMed: An evidence-based systematic review of umckaloabo (Pelargonium sidoides) by the Natural Standard Research Collaboration. PubMed: Genetic alterations for increased coumarin production lead to metabolic changes in the medicinally important Pelargonium sidoides DC (Geraniaceae). PubMed: Determination of umckalin in commercial tincture and phytopreparations containing Pelargonium sidoides by HPLC: comparison of sample preparation procedures. PubMed: Efficacy and tolerability of EPs 7630 tablets in patients with acute bronchitis: a randomised, double-blind, placebo-controlled dose-finding study with a herbal drug preparation from Pelargonium sidoides. PubMed: Efficacy and tolerability of EPs 7630 in children and adolescents with acute bronchitis - a randomized, double-blind, placebo-controlled multicenter trial with a herbal drug preparation from Pelargonium sidoides roots. PubMed: Efficacy and tolerability of EPs 7630 in patients (aged 6-18 years old) with acute bronchitis. PubMed: Benzopyranones and their sulfate esters from Pelargonium sidoides. PubMed: Treatment of acute rhinosinusitis with the preparation from Pelargonium sidoides EPs 7630: a randomized, double-blind, placebo-controlled trial. PubMed: Components derived from Pelargonium stimulate macrophage killing of Mycobacterium species. PubMed: A historical, scientific and commercial perspective on the medicinal use of Pelargonium sidoides (Geraniaceae). PubMed: Efficacy of an aqueous Pelargonium sidoides extract against herpesvirus. PubMed: Pelargonium sidoides extract for acute respiratory tract infections. PubMed: Anti-infective mode of action of EPs 7630 at the molecular level. PubMed: A broad review of commercially important southern African medicinal plants. PubMed: EPs 7630 improves acute bronchitic symptoms and shortens time to remission. Results of a randomised, double-blind, placebo-controlled, multicentre trial. PubMed: A detailed view on the constituents of EPs 7630. PubMed: Extract of Pelargonium sidoides (EPs 7630) displays anti-infective properties by enhanced phagocytosis and differential modulation of host-bacteria interactions. PubMed: Pelargonium sidoides for acute bronchitis: a systematic review and meta-analysis. PubMed: Aqueous ethanolic extract of the roots of Pelargonium sidoides--new scientific evidence for an old anti-infective phytopharmaceutical. PubMed: Efficacy of a pelargonium sidoides preparation in patients with the common cold: a randomized, double blind, placebo-controlled clinical trial. PubMed: [Pelargonium sidoides-extract (EPs 7630): registration confirms efficacy and safety]. PubMed: Allergic reactions to medicines derived from Pelargonium species. PubMed: Large molecules as anti-adhesive compounds against pathogens. PubMed: An extract of Pelargonium sidoides (EPs 7630) inhibits in situ adhesion of Helicobacter pylori to human stomach. PubMed: Treatment of acute bronchitis with a liquid herbal drug preparation from Pelargonium sidoides (EPs 7630): a randomised, double-blind, placebo-controlled, multicentre study. PubMed: Liquid herbal drug preparation from the root of Pelargonium sidoides is effective against acute bronchitis: results of a double-blind study with 124 patients. PubMed: Mass spectroscopic characterisation of oligomeric proanthocyanidins derived from an extract of Pelargonium sidoides roots (EPs 7630) and pharmacological screening in CNS models. PubMed: In vitro evaluation of antibacterial and immunomodulatory activities of Pelargonium reniforme, Pelargonium sidoides and the related herbal drug preparation EPs 7630. PubMed: Treatment of rats with the Pelargonium sidoides extract EPs 7630 has no effect on blood coagulation parameters or on the pharmacokinetics of warfarin. PubMed: EPs 7630, an extract from Pelargonium sidoides roots inhibits adherence of Helicobacter pylori to gastric epithelial cells. PubMed: Fascinating metabolic pools of Pelargonium sidoides and Pelargonium reniforme, traditional and phytomedicinal sources of the herbal medicine Umckaloabo. PubMed: EPs 7630-solution--an effective therapeutic option in acute and exacerbating bronchitis. PubMed: Extract of Pelargonium sidoides (EPs 7630) improves phagocytosis, oxidative burst, and intracellular killing of human peripheral blood phagocytes in vitro. PubMed: Pelargonium sidoides preparation (EPs 7630) in the treatment of acute bronchitis in adults and children. PubMed: Inhibition of lipopolysaccharid-induced sickness behavior by a dry extract from the roots of Pelargonium sidoides (EPs 7630) in mice. PubMed: Extract of Pelargonium sidoides (EPs 7630) inhibits the interactions of group A-streptococci and host epithelia in vitro. PubMed: Nitric oxide synthase and cytokines gene expression analyses in Leishmania-infected RAW 264.7 cells treated with an extract of Pelargonium sidoides (Eps 7630). PubMed: Treatment of acute bronchitis in adults with a pelargonium sidoides preparation (EPs 7630): a randomized, double-blind, placebo-controlled trial. PubMed: Tannins and related compounds induce nitric oxide synthase and cytokines gene expressions in Leishmania major-infected macrophage-like RAW 264.7 cells. PubMed: A new approach to pharmacological effects on ciliary beat frequency in cell cultures--exemplary measurements under Pelargonium sidoides extract (EPs 7630). PubMed: Efficacy of extract of Pelargonium sidoides in children with acute non-group A beta-hemolytic streptococcus tonsillopharyngitis: a randomized, double-blind, placebo-controlled trial. PubMed: Pharmacological profile of extracts of Pelargonium sidoides and their constituents. PubMed: Efficacy and safety of an extract of Pelargonium sidoides (EPs 7630) in adults with acute bronchitis. A randomised, double-blind, placebo-controlled trial. PubMed: Immunomodulatory principles of Pelargonium sidoides. PubMed: Antibacterial activity of extracts and constituents of Pelargonium sidoides and Pelargonium reniforme.